Abstract
Peptide-based antibiotics might help containing the rising tide of antimicrobial resistance. We developed SB056, a semi-synthetic peptide with a dimeric dendrimer scaffold, active against both Gram-negative and Gram-positive bacteria. Being the mechanism of SB056 attributed to disruption of bacterial membranes, we enhanced the amphiphilic profile of the original, empirically derived sequence [WKKIRVRLSA-NH2] by interchanging the first two residues [KWKIRVRLSA-NH2], and explored the effects of this modification on the interaction of peptide, both in linear and dimeric forms, with model membranes and on antimicrobial activity. Results obtained against Escherichia coli and Staphylococcus aureus planktonic strains, with or without salts at physiological concentrations, confirmed the added value of dendrimeric structure over the linear one, especially at physiological ionic strength, and the impact of the higher amphipathicity obtained through sequence modification on enhancing peptide performances. SB056 peptides also displayed intriguing antibiofilm properties. Staphylococcus epidermidis was the most susceptible strain in sessile form, notably to optimized linear analog lin-SB056-1 and the wild-type dendrimer den-SB056. Membrane affinity of all peptides increased with the percentage of negatively charged lipids and was less influenced by the presence of salt in the case of dendrimeric peptides. The analog lin-SB056-1 displayed the highest overall affinity, even for zwitterionic PC bilayers. Thus, in addition to electrostatics, distribution of charged/polar and hydrophobic residues along the sequence might have a significant role in driving peptide–lipid interaction. Supporting this view, dendrimeric analog den-SB056-1 retained greater membrane affinity in the presence of salt than den-SB056, despite the fact that they bear exactly the same net positive charge.
Similar content being viewed by others
References
Batoni G, Maisetta G, Brancatisano FL, Esin S, Campa M (2011) Use of antimicrobial peptides against microbial biofilms: advantages and limits. Curr Med Chem 18:256–2579
Brancatisano FL, Maisetta G, Di Luca M, Esin S, Bottai D, Bizzarri R, Campa M, Batoni G (2014) Inhibitory effect of the human liver-derived antimicrobial peptide hepcidin 20 on biofilms of polysaccharide intercellular adhesin (PIA)-positive and PIA-negative strains of Staphylococcus epidermidis. Biofouling 30:435–446
Breukink E, Van Kraaij C, Demel RA, Siezen RJ, Kuipers OP, De Kruijff B (1997) The C-terminal region of nisin is responsible for the initial interaction of nisin with the target membrane. Biochemistry 36:6968–6976
Bruschi M, Pirri G, Giuliani A, Nicoletto SF, Baster I, Scorciapino MA, Casu M, Rinaldi AC (2010) Synthesis, characterization, antimicrobial activity and LPS-interaction properties of SB041, a novel dendrimeric peptide with antimicrobial properties. Peptides 31:1459–1467
Christiaens B, Symoens S, Vanderheyden S, Engelborghs Y, Joliot A, Prochiantz A, Vandekerckhove J, Rosseneu M, Vanloo B (2002) Tryptophan fluorescence study of the interaction of penetratin peptides with model membranes. Eur J Biochem 269:2918–2926
Coccia C, Rinaldi AC, Luca V, Barra D, Bozzi A, Di Giulio A, Veerman EC, Mangoni ML (2011) Membrane interaction and antibacterial properties of two mildly cationic peptide diastereomers, bombinins H2 and H4, isolated from Bombina skin. Eur Biophys J 40:577–588
Di Luca M, Maccari G, Maisetta G, Batoni G (2015) BaAMPs: the database of biofilm-active antimicrobial peptides. Biofouling 31:193–199
Diamond G, Beckloff N, Weinberg A, Kisich KO (2009) The roles of antimicrobial peptides in innate host defense. Curr Pharm Des 15:2377–2392
Epand RM, Epand RF (2009) Domains in bacterial membranes and the action of antimicrobial agents. Mol BioSyst 5:580–587
Epand RF, Ramamoorthy A, Epand RM (2006) Membrane lipid composition and the interaction of pardaxin: the role of cholesterol. Protein Pept Lett 13:1–5
Falciani C, Brunetti J, Pagliuca C, Menichetti S, Vitellozzi L, Lelli B, Pini A, Bracci L (2010) Design and in vitro evaluation of branched peptide conjugates: turning nonspecific cytotoxic drugs into tumor-selective agents. ChemMedChem 5:567–574
Falciani C, Lozzi L, Pollini S, Luca V, Carnicelli V, Brunetti J, Lelli B, Bindi S, Scali S, Di Giulio A, Rossolini GM, Mangoni ML, Bracci L, Pini A (2012) Isomerization of an antimicrobial peptide broadens antimicrobial spectrum to gram-positive bacterial pathogens. PLoS ONE 7:e46259
Giuliani A, Rinaldi AC (2011) Beyond natural antimicrobial peptides: multimeric peptides and other peptidomimetic approaches. Cell Mol Life Sci 68:2255–2266
Giuliani A, Pirri G, Bozzi A, Di Giulio A, Aschi M, Rinaldi AC (2008) Antimicrobial peptides: natural templates for synthetic membrane-active compounds. Cell Mol Life Sci 65:2450–2460
Kyte J, Doolittle RF (1892) A simple method for displaying the hydropathic character of a protein. J Mol Biol 157:105–132
Laxminarayan R, Duse A, Wattal C, Zaidi AK, Wertheim HF, Sumpradit N, Vlieghe E, Hara GL, Gould IM, Goossens H, Greko C, So AD, Bigdeli M, Tomson G, Woodhouse W, Ombaka E, Peralta AQ, Qamar FN, Mir F, Kariuki S, Bhutta ZA, Coates A, Bergstrom R, Wright GD, Brown ED, Cars O (2013) Antibiotic resistance-the need for global solutions. Lancet Infect Dis 13:1057–1098
Lind TK, Polcyn P, Zielinska P, Cárdenas M, Urbanczyk-Lipkowska Z (2015) On the antimicrobial activity of various peptide-based dendrimers of similar architecture. Molecules 20:738–753
Luca V, Stringaro A, Colone M, Pini A, Mangoni ML (2013) Esculentin(1-21), an amphibian skin membrane-active peptide with potent activity on both planktonic and biofilm cells of the bacterial pathogen Pseudomonas aeruginosa. Cell Mol Life Sci 70:2773–2786
Luganini A, Giuliani A, Pirri G, Pizzuto L, Landolfo S, Gribaudo G (2010) Peptide-derivatized dendrimers inhibit human cytomegalovirus infection by blocking virus binding to cell surface heparin sulfate. Antiviral Res 85:532–540
Mangoni ML, Fiocco D, Mignogna G, Barra D, Simmaco M (2003) Functional characterisation of the 1-18 fragment of esculentin-1b, an antimicrobial peptide from Rana esculenta. Peptides 24:1771–1777
Mangoni ML, Maisetta G, Di Luca M, Gaddi LM, Esin S, Florio W, Brancatisano FL, Barra D, Campa M, Batoni G (2008) Comparative analysis of the bactericidal activities of amphibian peptide analogues against multidrug-resistant nosocomial bacterial strains. Antimicrob Agents Chemother 52:85–91
Manzo G, Scorciapino MA, Wadhwani P, Bürck J, Montaldo NP, Pintus M, Sanna R, Casu M, Giuliani A, Pirri G, Luca V, Ulrich AS, Rinaldi AC (2015) Enhanced amphiphilic profile of a short β-stranded peptide improves its antimicrobial activity. PLoS ONE 10:e0116379
Marcellini L, Borro M, Gentile G, Rinaldi AC, Stella L, Aimola P, Barra D, Mangoni ML (2009) Esculentin-1b(1-18)–a membrane-active antimicrobial peptide that synergizes with antibiotics and modifies the expression level of a limited number of proteins in Escherichia coli. FEBS J 276:5647–5664
Opar A (2007) Bad drugs need more drugs. Nature Rev Drug Discov 6:943–944
Percival SL, Suleman L, Vuotto C, Donelli G (2015) Healthcare-associated infections, medical devices and biofilms: risk, tolerance and control. J Med Microbiol 64:323–334
Peschel A, Sahl HG (2006) The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat Rev Microbiol 4:529–536
Pini A, Giuliani A, Falciani C, Runci Y, Ricci C, Lelli B, Malossi M, Neri P, Rossolini GM, Bracci L (2005) Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification. Antimicrob Agents Chemother 7:2665–2672
Polcyn P, Zielinska P, Zimnicka M, Troć A, Kalicki P, Solecka J, Laskowska A, Urbanczyk-Lipkowska Z (2013) Novel antimicrobial peptide dendrimers with amphiphilic surface and their interactions with phospholipids—insights from mass spectrometry. Molecules 18:7120–7144
Rotem S, Mor A (2009) Antimicrobial peptide mimics for improved therapeutic properties. Biochim Biophys Acta 1788:1582–1592
Sadler K, Tam JP (2002) Peptide dendrimers: applications and synthesis. Rev Mol Biotechnol 90:195–229
Scorciapino MA, Rinaldi AC (2012) Antimicrobial peptidomimetics: reinterpreting nature to deliver innovative therapeutics. Front Immunol 3:1–4
Scorciapino MA, Pirri G, Vargiu AV, Ruggerone P, Giuliani A, Casu M, Bürck J, Wadhwani P, Ulrich AS, Rinaldi AC (2012) A novel dendrimeric peptide with antimicrobial properties: structure-function analysis of SB056. Biophys J 102:1039–1048
Shai Y (2006) Mode of action of membrane active antimicrobial peptides. Biopolymers 66:236–248
Shaw N (1974) Lipid composition as a guide to the classification of bacteria. Adv Appl Microbiol 17:63–108
Stach M, Siriwardena TN, Köhler T, van Delden C, Darbre T, Reymond JL (2014) Combining topology and sequence design for the discovery of potent antimicrobial peptide dendrimers against multidrug-resistant Pseudomonas aeruginosa. Angew Chem Int Ed Engl 53:12827–12831
Tam JP, Lu YA, Yang JL (2002) Antimicrobial dendrimeric peptides. Eur J Biochem 269:923–932
Vega NM, Gore J (2014) Collective antibiotic resistance: mechanisms and implications. Curr Opin Microbiol 21:28–34
Wilmes M, Sahl HG (2014) Defensin-based anti-infective strategies. Int J Med Microbiol 304:93–99
World Health Organization (2014) Antimicrobial resistance: global report on surveillance. WHO, Geneva. http://apps.who.int/iris/bitstream/10665/112642/1/9789241564748_eng.pdf?ua=1. Accessed 16 Aug 2015
Yount NY, Yeaman MR (2013) Peptide antimicrobials: cell wall as a bacterial target. Ann N Y Acad Sci 1277:127–138
Zasloff M (2002) Antimicrobial peptides of multicellular organisms. Nature 415:389–395
Zhao H, Kinnunen PK (2002) Binding of the antimicrobial peptide temporin L to liposomes assessed by Trp fluorescence. J Biol Chem 277:25170–25177
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
ACR is the recipient of a Grant from the Sardinia Regional Government (http://www.regione.sardegna.it/), L.R. 7/2007, bando 2009, Grant Number: CRP-17385. The Ordine Nazionale dei Biologi is acknowledged for the fellowship provided to VL. Regione Autonoma della Sardegna (P.O.R. FSE 2007–2013) is acknowledged for the fellowships to GM and IS.
Conflict of interest
AG and GP are minor shareholders of Spider Biotech S.r.l.
Additional information
Handling Editor: J. D. Wade.
Rights and permissions
About this article
Cite this article
Batoni, G., Casu, M., Giuliani, A. et al. Rational modification of a dendrimeric peptide with antimicrobial activity: consequences on membrane-binding and biological properties. Amino Acids 48, 887–900 (2016). https://doi.org/10.1007/s00726-015-2136-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00726-015-2136-5